Tutkimuksia ja lähdeviitteitä

  • Löfberg L (2018) Voiko pelimuotoisilla kognitiivisilla harjoitteilla edesauttaa muistipotilaiden toimintakykyä? 2. Maallikolle laadittu tiivis vastaus. https://memoera.fi/index.php/1753-2/



Bamidis, P. D., Fissler, P., Papageorgiou, S. G., Zilidou, V., Konstantinidis, E. I., Billis, A. S., Romanopoulou, E., Karagianni, M., Beratis, I., Angeliki, T., Tsilikopoulou, G., Grigoriadou, E., Ladas, A., Kyrillidou, A., Tsolaki, A., Frantzidis, C., Sidiropoulos, E., Siountas, A., Matsi, S., Papatriantafyllou, J., Margioti, E., Nika, A., Schlee, W., Elbert, T., Tsolaki, M., Vivas, A. B. & Kolassa I. (2015) Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci., 7:152.
Mura, G., Carta, M. G., Sancassiani, F., Machado, S. & Prosperini, L. (2017) Active exergames to improve cognitive functioning in neurological disabilities: a systematic review and meta-analysis. Eur J Phys Rehabil Med., DOI: 10.23736/S1973-9087.17.04680-9.
https://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y9999N00A17102501 (viitattu 26.1.2018)
Rinne, J., Rosenvall, A., Erkinjuntti, T., Koponen, H., Löppönen, M., Raivio, M., Strandberg, T., Vanninen, R., Vataja, R., Tuunainen, A., Hartikainen, S., Hietanen, M., Hänninen, T., Kivipelto, M., Melkas, S., Ojala, M., Pitkälä, K., Voutilainen, P. (2017) Suomalaisen Lääkäriseuran Duodecimin, Societas Gerontologica Fennican, Suomen Geriatrit -yhdistyksen, ja Suomen Yleislääketieteen yhdistyksen asettama työryhmä. Muistisairaudet (online). Käypä hoito -suositus. Helsinki: Suomalainen Lääkäriseura Duodecim, 133 (8),756-7.
http://www.terveysportti.fi/xmedia/duo/duo13663a.pdf (viitattu 26.1.2018)
Stanmore, E., Stubbs, B., Vancampfort, D., de Bruin, E. D. & Firth, J. (2017) The effect of active video games on cognitive functioning in clinical and non-clinical populations: A meta-analysis of randomized controlled trials. Neurosci Biobehav Rev., 78: 34-43.
Wiloth, S., Werner, C., Lemke, N. C., Bauer, J. & Hauer, K. (2017) Motor-cognitive effects of a computerized game-based training method in people with dementia: a randomized controlled trial. Aging Ment Health., DOI: 10.1080/13607863.2017.1348472
http://www.tandfonline.com/doi/abs/10.1080/13607863.2017.1348472?journalCode=camh20 (viitattu 26.1.2018)


Oxford:  Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox
NC, Gamst A, Holtzman DM, Jagust WK, Petersen RC, Snyder
PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild
cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging and Alzheimer’s Association workgroup. Alzheimers Dement 7:270–279.
Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, Kong E, Larraburo Y, Rolle C, Johnston E, Gazzaley A
(2013) Video game training enhances cognitive control in
older adults. Nature 501:97–101.
Barnett JH, Blackwell AD, Sahakian BJ, Robbins TW (2016) The
Paired Associates Learning (PAL) test: 30 years of CANTAB
Translational Neuroscience from Laboratory to Bedside in
Dementia Research. In: Current topics in behavioral neuroscience: translational neuropsychopharmacology (Robbins
TW, Sahakian BJ, eds), vol. 28, pp. 449–474.
Beddington J, Cooper CL, Field J, Goswami U, Huppert FA, Jenkins
R, Jones HS, Kirkwood TB, Sahakian BJ, Thomas SM (2008) The
mental wealth of nations. Nature 455:1057–1060.
Belleville S (2008) Cognitive training for persons with mild cognitive impairment. Int Psychogeriatr 20:57–66.
Benedict RH (1997) Brief visuospatial test-revised: professional
manual. Odessa, FL: PAR.
Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins, TW,
Hodges JR (2004) Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord 17:42–48.
Brühl A, Sahakian BJ (2016) Drugs, games, and devices for
enhancing cognition: implications for work and society. Ann
N Y Acad Sci 1369:195–217.
Buettner LL, Fitzsimmons S, Atav S, Sink K (2011) Cognitive stimulation for apathy for probable early-stage Alzeimer’s. J Aging
Res 480890.
Collins PY et al. (2011) Grand challenges in global mental health.
Nature 475:27–30.
DeCarli C (2003) Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neuol 2:15–21.
de Rover M, Pironti VA, McCabe JA, Acosta-Cabronero J, Sergio
Arana F, Morein-Zamir S, Hodges JR, Robbins TW, Fletcher PC,
Nestor PJ, Sahakian BJ (2011). Hippocampal dysfunction in
patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning
task. Neuropsychologia 49:2060–2070.
Dickerson BC, Sperling RA (2008) Functional abnormalities of
the medial temporal lobe memory system in mild cognitive
impairment and Alzheimer’s disease: insights from functional MRI studies. Neuropsychologia 46:1624–1635.
Eagger SA, Levy R, Sahakian BJ (1992) Tacrine in Alzheimer’s disease. Acta Neurol Scand Suppl 139:75–80.
Feldman HH et al (2007) Effect of rivastigmine on delay to diagnosis of Alzheimer’s disease from mild cognitive impairment:
the InDDEx study. Lancet Neurol 6:501–512.
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”.
A practical method for grading the cognitive state of patients
for the clinician. J Psychiatr Res 12:189–198.
Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela M (2011)
Cognitive and memory training in adults at risk of dementia:
a systematic review. BMC Geriatr 11:55.
Huntley JD, Gould RL, Liu K, Smith M, Howard RJ (2015) Do cognitive interventions improve general cognition in dementia?
A meta-analysis and meta-regression. BMJ Open 5:e005247.
Insel TR, Sahakian BJ (2012) Drug research: a plan for mental illness. Nature 483:269.
Insel TR, Voon V, Nye JS, Brown VJ, Altevogt BM, Bullmore ET, Goodwin GM, Howard RJ, Kupfer DJ, Malloch G, Marston HM, Nutt
DJ, Robbins TW, Stahl SM, Tricklebank MD, Williams JH, Sahakian BJ (2013). Innovative solutions to novel drug development
in mental health. Neurosci Biobehav Rev 37:2438–2444.
Jean L, Bergeron ME, Thivierge S, Simard M (2010) Cognitive
intervention programs for individuals with mild cognitive
impairment: systematic review of the literature. Am J Geriatr
Psychiatry 18:281–296.
Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ (2016) Modafnil improves episodic memory and working memory cognition in patients
with remitted depression: a double-blind, randomized, placebo-controlled study. Biol Psychiatry Cogn Neurosci Neuroimaging 2:115–122.
Kirchhoff BA, Anderson BA, Smith SE, Barch DM, Jacoby LL (2012)
Cognitive training-related changes in hippocampal activity associated with recollection in older adults. Neuroimage
Li H, Li J, Li N, Li B, Wang P, Zhou T (2011) Cognitive intervention
for persons with mild cognitive impairment: a meta-analysis.
Ageing Res Rev 10:285–296.
Manera V, Petit P-D, Derreumaux A, Orvieto I, Romagnoli M, Luttle G, David R, Robert PH (2015) ‘Kitchen and cooking,’ a serious game for mild cognitive impairment and Alzheimer’s
disease: a pilot study. Front Aging Neurosci 17:7–24.
Marin RS (1996) Apathy: concept, syndrome, neural mechanisms,
and treatment. Semin Clin Neuropsychiatry 1:304–314.
Martin M, Clare L, Altgassen AM, Cameron MH, Zehender F (2011)
Cognition-based interventions for healthy older people and
people with mild cognitive impairment. Cochrane Database
Syst Rev 19:CD006220.
Moher D, Schulz KF, Atlman DG (2001) The CONSORT statement: revised recommendations for improving the quality of
reports of parallel-group randomised trails. Lancet 357:1191–
Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R
(2009) A systematic review of neuropsychiatric symptoms in
mild cognitive impairment. J Alzheimers Dis 18:11–30.
Nathan PJ, Ying Lim Y, Abbott R, Galluzzi S, Marizzoni M, Babiloni
C, et al. (2017) Association between CSF biomarkers, hippocampal volume and cognitive function in patients with
amnestic mild cognitive impairment (MCI). Neuobiol Aging
Nelson HE (1982) National Adult Reading Test (NART): for the
assessment of premorbid intelligence in patients with
dementia: test manual. Windsor, UK: NFER-Nelson.
Petersen RC (2011) Clinical practice. Mild cognitive impairment.
N Engl J Med 364:2227–2234.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris
S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck
CH, Thal LJ (2005) Vitamin E and donepezil for the treatment of
mild cognitive impairment. N Engl J Med 352:2379–2388.
Reijnders J, van Heugten C, van Boxtel M (2013) Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev
Rosen AC, Sugiura L, Kramer JH, Whitfeld-Gabrieli S, Gabrieli
JD (2011) Cognitive training changes hippocampal function
in Mild Cognitive Impairment: a pilot study. J Alzheimers Dis
Sahakian BJ (2014) What do experts think we should do to
achieve brain health? Neurosci Biobehav Rev 43:240–258.
Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot
M, Robbins TW (1988) A comparative study of visuospatial
memory and learning in Alzheimer-type dementia and Parkinson’s disease. Brain 111:695–718.
Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S,
Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer’s disease: assessment of attentional
and mnemonic function using CANTAB. Psychopharmacology (Berl) 110:395–401.
Sahakian BJ et al. (2010) A UK strategy for mental health and
wellbeing. Lancet 375:1854–1855.
Sahakian BJ, Brühl AB, Cook J, Killikelly C, Savulich G, Piercy T,
Hafzi J, Perez J, Fernandez-Egea E, Suckling J, Jones PB (2015)
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.
Philos Trans R Soc Lond B Biol Soc 370:20140214.
Savulich G, Piercy T, Brühl AB, Fox C, Suckling J, Rowe JB, O’Brien
JT, Sahakian BJ (2017) Focusing the neuroscience and societal
implications of cognitive enhancers. Clin Pharmacol Ther
Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS):
recent evidence and development of a shorter version. Clinical gerontology: a guide to assessment and intervention,
pp165–173, New York: The Haworth Press.
Simon SS, Yokomizo JE, Bottino CM (2012) Cognitive intervention
in amnestic mild cognitive impairment: a systematic review.
Neurosci Biobehav Rev 36:1163–1178.
Strenziok M, Parasuraman R, Clarke E, Cisler DS, Thompson JC,
Greenwood PM (2014) Neurocognitive enhancement in older
adults: comparison of three cognitive training tasks to test a
hypothesis of training transfer in brain connectivity. Neuroimage 85:1027–1039.
Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD,
Iddon JL, Robbins TW, Sahakian BJ (2001) Early detection and
differential diagnosis of Alzheimer’s Disease and depression
with neuropsychological tasks. Dement Geriatr Cogn Disord
Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen
L, Mayorga AJ, Wang D, Brashear HR, Nye JS (2008) Safety
and effcacy of galantamine in subjects with mild cognitive
impairment. Neurology 70:2024–2035.
World Health Organization (April 2016). Dementia. Available
Accessed January 2, 2017.
Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P (2011) A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 168:472–485.
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370.